Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis.
Akaninyene Asuquo OtuFelix BongominRohit BazazChris HarrisDavid W DenningChris KosmidisPublished in: Mycoses (2018)
Micafungin may be safely administered via an OPAT service. Micafungin therapy was associated with an improvement or stability in QoL scores in at least 50% of the patients across the four domains.